COMPOSTOS E COMPOSIÇÕES COMO INIBIDORES DE QUINASES PROTEICAS

The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to beat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal acti...

Full description

Saved in:
Bibliographic Details
Main Authors JON LOREN, LAWRENCE B. PEREZ, CLINTON BROOKS, LASZLO REVESZ, WOJCIECH WRONA, PAUL W. MANLEY, WERNER BREITENSTEIN, XIAOLIN LI, JULIET NABBAKA, VALENTINA MOLTENI, XIAODONG LIU, DONATELLA CHIANELLI
Format Patent
LanguagePortuguese
Published 26.11.2013
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to beat or prevent diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases or disorders that involve abnormal activation of c-kit, PDGFRα and PDGFR kinases. Formula (I).
Bibliography:Application Number: BR2007PI18677